Just one-fifth of adults, and an even lower proportion of children and adolescents, with type 1 diabetes in the T1D Exchange registry currently meet the ADA target for glycemic control, US researchers report.
The DREAM5 randomized trial has confirmed the efficacy of closed-loop insulin delivery with the MD-logic algorithm in adolescents and young adults without remote monitoring.
The incidence of childhood type 1 diabetes continues to increase across Europe, with the number of cases potentially doubling in the next 20 years, an analysis of 25 years of EURODIAB registry data shows.
The effect of sleep duration on glucose regulation and cardiometabolic risk is becoming an increasingly high-profile issue. medwireNews takes a look at the latest evidence, which shows the gravity of the problem but also offers some solutions.
Professor Moshe Phillip tells medwireNews why he believes the artificial pancreas will be of particular benefit for adolescents and young adults with type 1 diabetes.